Afghanistan makes first use of new GSK polio vaccine
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline's new bivalent oral polio vaccine (bOPV) is being used for the first time in a three-day polio vaccination drive in Afghanistan targeting children aged under five years.